Type to search

Medable Selected by GSK to Power Decentralized and Hybrid Clinical Trials Across Global Product Portfolio | Pharmtech Focus
New Study: Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors | Pharmtech Focus
Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures, and Tiger Global | Pharmtech Focus